Figure 2.

Clinical remission and corticosteroid-free clinical remission in patients with CD [A] and UC [B] who completed the sub-study on Q8W dosing. Remission, defined as an HBI score ≤4 for patients with CD, or a partial Mayo score ≤2 with no sub-score >1 for patients with UC, and CS use was assessed at baseline [Week 0] as well as Weeks 8, 16, and 56. Week 56 includes patients who dropped out before Week 56 with EOSS values mapped to Week 56. EOSS, end of sub-study; CD, Crohn’s disease; CI, confidence interval; CS, corticosteroid; HBI, Harvey-Bradshaw Index; Q8W, every 8 weeks; UC, ulcerative colitis.